Hudson Bay Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,000
Closed -$3.65M 1453
2025
Q4
$3.65M Sell
55,000
-5,000
-8% -$323K 0.01% 579
2025
Q3
$4.04M Buy
+60,000
New +$4.75M 0.01% 606
2025
Q1
Sell
-400,023
Closed -$31.1M 1345
2024
Q4
$31.1M Buy
400,023
+310,023
+344% +$23M 0.11% 184
2024
Q3
$6.03M Sell
90,000
-185,000
-67% -$15.2M 0.02% 379
2024
Q2
$31.2M Buy
+275,000
New +$34.8M 0.15% 99
2023
Q4
Sell
-10,000
Closed -$933K 779
2023
Q3
$933K Buy
+10,000
New +$1.13M 0.01% 573
2022
Q4
Sell
-12,500
Closed -$1.01M 1023
2022
Q3
$1.01M Buy
+12,500
New +$1.06M 0.01% 835

Other funds holding DXCM

Hudson Bay Capital Management's DXCM Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 55,000 shares — an estimated $3.65M sold.

Hudson Bay Capital Management first reported a position in DXCM in Q3 2022 and held it in 7 quarters. The position peaked at $31.2M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Hudson Bay Capital Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 55,000 DexCom shares in Q1 2026, an estimated $3.65M.
  • Hudson Bay Capital Management first reported a position in DexCom in Q3 2022 and held it in 7 quarters.
  • Hudson Bay Capital Management's DexCom position peaked at $31.2M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.